je.st
news
Tag: drug
Canada finalises drug labelling regulations
2014-07-03 01:00:00| Packaging Gateway
The Government of Canada has finalised new plain language labelling regulations, which will make drug labels and packaging information easier to read and understand.
Tags: canada
drug
regulations
labelling
Cook Pharmica, LLC And Selexis SA Establish Customized Biologic Drug Development And Manufacturing Services Platform
2014-07-02 10:43:44| drugdiscoveryonline Home Page
Cook Pharmica, LLC, a leading biopharmaceutical contract development and manufacturing organization (CDMO), and Selexis SA, a serial innovation company focused on biologic drug discovery and mammalian cell line development, have built a platform program to offer biopharmaceutical clients an integrated development and manufacturing solution for biologic drugs
Tags: services
development
llc
drug
Vertex Submits Supplemental New Drug Application (sNDA) To U.S. Food And Drug Administration For Use Of KALYDECO (ivacaftor) In People 18 And Older With Cystic Fibrosis Who Have The R117H Mutation
2014-07-02 10:30:30| drugdiscoveryonline Home Page
Vertex Pharmaceuticals Incorporated recently announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the approval of KALYDECO in people with cystic fibrosis (CF) ages 18 and older who have the R117H mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
Euroscreen To Present ESN364; An Innovative Drug Candidate For The Treatment Of Women's Health Disorders At The ICE/ENDO Meeting
2014-07-02 10:27:34| drugdiscoveryonline Home Page
Euroscreen, a private drug development company, announced today that its ESN364 Phase I clinical candidate, will be presented at the ICE/ENDO Meeting on Sunday, June 22nd (Chicago, IL)
Tags: the
health
present
meeting
Leading Foundations Publish Recommendations To Accelerate Drug Repurposing For Neurodegenerative Diseases
2014-07-02 09:34:12| drugdiscoveryonline Home Page
A new peer-reviewed publication from the Alzheimer's Drug Discovery Foundation (ADDF) and The Michael J. Fox Foundation for Parkinson's Research (MJFF) offers strategic insight on how philanthropy, industry and government organizations can advance repurposing of U.S. Food and Drug Administration (FDA)-approved drugs for the treatment of neurodegenerative diseases
Tags: leading
drug
recommendations
publish
Sites : [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] next »